Lantern Pharma Inc. (LTRN) News
Follow Lantern Pharma Inc. (LTRN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Lantern Pharma hosts webinar on Open—Medicine AI multi-agentic drug development platform
Lantern Pharma hosted a live webinar to discuss its Open—Medicine AI multi-agentic platform for drug development.Key Highlights:Original SEC Filing: Lantern Pharma Inc. [ LTRN ] - 8-K - Sep. 23, 2026This is an AI-powered
REGULATION | Sep 24, 2026, 10:04 AM UTC
L
Lantern Pharma to present Open-Medicine AI roadmap, demo, commercial model in live webinar
Lantern Pharma to present Open-Medicine AI growth plan, live demo and commercial model in a webinar today at 12:30 PM ET.Key Highlights:Original SEC Filing: Lantern Pharma Inc. [ LTRN ] - 8-K - Sep. 23, 2026This is an AI
REGULATION | Sep 23, 2026, 11:53 AM UTC
L
Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using artificial intelligence and genomic data to develop precision oncology therapies, will present the growth plan for Open-Medicine AI
NEWS | Sep 23, 2026, 11:45 AM UTC
M
Lantern Pharma gets USPTO Notice of Allowance for LP-284 patent
Lantern Pharma said the USPTO issued a Notice of Allowance for its LP—284 treatment patent application for aggressive B—cell lymphomas.
REGULATION | Sep 22, 2026, 11:45 AM UTC
L
New to The Street plans 6:30 PM ET broadcast featuring LTRN, SSGC, CAST
New to The Street said it will broadcast at 6:30 PM ET across Bloomberg U.S., Latin America and MENA, featuring Lantern Pharma (LTRN), SafeSpace Global (SSGC) and FreeCast (CAST). It also cited an October 3 Southeast Asi
EQUITY | Sep 05, 2026, 02:51 PM UTC
L
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASD
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (SGCC)
EQUITY | Aug 29, 2026, 01:22 PM UTC
L
LTRN Lantern Pharma to advance EMA-cleared phase 1B/2 trial of lp-184 (zirdafulven) in biomarker-selected advanced bladder cancer
LTRN Lantern Pharma to advance EMA-cleared phase 1B/2 trial of lp-184 (zirdafulven) in biomarker-selected advanced bladder cancer
EQUITY | Jul 28, 2026, 11:45 AM UTC
H
Lantern Pharma Launches ZetaOmics, A Computational-Biology Module Of Its WithZeta.ai Co-Scientist Platform
ZetaOmics introduces an autonomous "Computational Biologist" persona (agent) that performs real, end-to-end bioinformatics and multi-omic analysis — across any cancer type, and is purpose-built for the rare and pediatric
EARNINGS | Jul 08, 2026, 11:33 AM UTC